Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

3(38%)

Results Posted

0%(0 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_2

50%

Ph phase_3

38%

Ph phase_4

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

4(50.0%)

Phase 3Large-scale testing

3(37.5%)

Phase 4Post-market surveillance

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(2)

Terminated(2)

Other(1)

Detailed Status

Completed2

Recruiting2

Active, not recruiting1

Terminated1

unknown1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 24 (50.0%)

Phase 33 (37.5%)

Phase 41 (12.5%)

Trials by Status

completed225%

recruiting225%

active_not_recruiting113%

terminated113%

unknown113%

withdrawn113%

Recent Activity

3 active trials

Showing 5 of 8

active_not_recruitingphase_3

Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)

NCT03040778

recruitingphase_2

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

NCT06494111

recruitingphase_2

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

NCT06912763

unknownphase_3

The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis

NCT05350124

completedphase_4

Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities

NCT04360889

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT03040778Phase 3

Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)

Active Not Recruiting

NCT06494111Phase 2

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

Recruiting

NCT06912763Phase 2

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

Recruiting

NCT05350124Phase 3

The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis

Unknown

NCT04360889Phase 4

Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities

Completed

NCT00002586Phase 2

13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer

Completed

NCT00162526Phase 2

Tocopherol is a Novel Treatment for Cancer Related Mucositis